Quarterly ResultJul 8, 2026, 08:06 AM
Zeo ScientifiX Q2 Revenue +124.6% to $2.58M; Net Loss Reduced
AI Summary
Zeo ScientifiX reported exceptional financial results for the quarter and six months ended April 30, 2026. The company achieved a 124.6% year-over-year revenue growth for the quarter, reaching $2,581,000, and a 79.9% increase for the six-month period, totaling $4,027,000. Gross margins remained strong at approximately 80.0%, and the net loss significantly decreased to $1.0 million for the six months, compared to $2.6 million in the prior year.
Key Highlights
- Revenue for the three months ended April 30, 2026, increased 124.6% to $2,581,000.
- Revenue for the six months ended April 30, 2026, grew 79.9% to $4,027,000.
- Maintained gross margins of approximately 80.0% for both six-month periods.
- Net loss reduced to approximately $1.0 million for the six months ended April 30, 2026.
- Growth driven by increased demand for allogenic biologic products in Florida.
Price Impact
More from ZEOX